Possible changes in the transmissibility of trachoma following MDA and transmission reduction: impli...
Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The role of mass drug administration (MDA) and the implementation of transmission reduction measures are essential to successfully control and eliminate a wide range of NTDs, including the ocular disease trachoma. Immunity to trachoma infection acts by reducing the duration of an individual's infectious period and by reducing their infectivity with...
Alternative Titles
Full title
Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_15091bc7abc34e9e8027f60cb22f4e3d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_15091bc7abc34e9e8027f60cb22f4e3d
Other Identifiers
ISSN
1756-3305
E-ISSN
1756-3305
DOI
10.1186/s13071-015-1133-6
